The Overdose Crisis Stopped Being Only About Opioids Years Ago. Treatment Still Hasn't Caught Up.
A new 86-source review lays out how fentanyl now travels with cocaine, meth, benzos and xylazine, and how few people get the one medicine we have.
Somewhere in Florida in the last few years, 2,882 people died with cocaine in their bodies. In 2,499 of those deaths, cocaine was not the only drug present. That ratio, nearly nine in ten, is the quiet center of a review published this week in Frontiers in Public Health by a Florida International University team led by N.K. Mandapati with senior author S. Aggarwal. They read 86 studies and government reports from 2010 to 2026 and assembled the picture everyone working the front line already lives inside: fentanyl rarely travels alone anymore.
We are running a one-drug treatment system for a crisis where nearly everyone is using several.
The review’s numbers are blunt. Cocaine-involved overdose death rates more than tripled, from 1.4 to 4.5 per 100,000, between 2012 and 2018; meth-type stimulant deaths rose from 0.8 to 3.9. Benzodiazepines showed up in 21% of opioid overdose deaths in 2017, up from under 9% in 1999. The DEA found the animal sedative xylazine in 30% of seized fentanyl powder in 2023 and in fentanyl mixtures in 48 of 50 states. One caveat in fairness: this is a narrative review, a careful reading of other people’s data, not a new dataset, and the authors did no pooling or formal bias scoring. But the direction is not in dispute. We saw the same pattern in New York this week, where cocaine-only deaths are climbing among older Black men even as fentanyl’s share falls.
Now set that against the treatment numbers in the same paper. In 2022, of American adults who needed opioid use disorder treatment, 55.2% got any treatment and only 25.1% got medication. And for the stimulants riding alongside fentanyl, there is still no FDA-approved medication at all. NIDA’s own summary says the best-studied treatment for meth use disorder is contingency management, small rewards for negative drug tests, and it remains one of the hardest treatments in American addiction care to get paid for.
If you use cocaine or meth and think fentanyl is someone else’s problem, the data says otherwise. Carry naloxone anyway, test what you can, and do not use alone. Those are not opioid-user rules anymore.
For providers, here is the do-this-week move: stop sorting intake by “primary substance” and start asking every patient what else they use, and what they think might be in it. Offer naloxone to every stimulant patient, not just opioid patients. Ask your billing team, by Friday, whether your state Medicaid program pays for contingency management yet, and if not, who in your state is piloting it.
The review’s authors propose an “adaptive polysubstance response framework.” The simpler version is this: treat the person standing in front of you, not the drug on the form.
Sources Cited
- 01.A
- 02.A
Filed Under
trendstreatmentpolicyPolysubstanceCocaineMethamphetamineXylazineContingency ManagementPeer-Reviewed ResearchOverdose
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
Washington Is Fighting Over Who Gets Credit for the Overdose Decline. Medicaid Will Decide Whether It Lasts.
CDC data show 65,724 predicted overdose deaths in the year ending June 2026, down 41.5% from the peak. The White House is claiming credit while Medicaid work requirements start January 1, 2027. Here is what the decline is actually built on.
The Crisis, By the NumbersHeroin Deaths Fell 90%. Nobody Won. Heroin Just Got Replaced.
New CDC provisional data show heroin-involved overdose deaths at about 1,600 for the year ending June 2026, down from a 2017 peak near 15,700. Why heroin disappeared, what replaced it, how the switch changes tolerance and withdrawal, and what still works.
The Crisis, By the NumbersNew York's Overdose Deaths Hit a Six-Year Low. The Crack-Era Generation Is Still Dying at Home.
NYC recorded 359 overdose deaths in Q2 2026, its lowest quarter since 2019. But Black New Yorkers 55–64 still die at 3x the citywide rate, 71% of deaths happen at home, and cocaine-only deaths are climbing.